Thu, 03 Sep 2026
The personal investment firms of titans like Stanley Druckenmiller are backing innovations in gene editing, drug discovery and more.
Terms of Use | Privacy Policy | Manage Cookies+ | Ad Choices | Accessibility & CC | About | Newsletters | Transcripts
Business News Top © 2024-2025